Globus Medical, Inc.

Healthcare · Medical - Devices

Overall research band Above average

Quality Above average

Valuation Above average

Balance sheet Exceptional

Market confirmation Very weak

One-minute company read

What this report can tell you now

What the company does

Globus Medical, Inc. is a global medical technology company headquartered in Audubon, Pennsylvania, focused on inventing, developing, and marketing healthcare solutions for musculoskeletal disorders. The company offers an extensive portfolio of spinal products, including fusion implants such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative diseases, deformities, tumors, and trauma. Globus Medical also provides advanced motion preservation technologies like dynamic stabilization, total disc replacement, and interspinous distraction devices, as well as interventional pain management options for vertebral compression fractures. Its regenerative biologic products include allografts and synthetic alternatives. Beyond spinal care, the company manufactures orthopedic trauma solutions, such as fracture plates, compression screws, intramedullary nails, and external fixation systems, and offers hip and knee joint reconstruction products.

The current research profile is Mixed Setup, with weak market confirmation. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC10.5%Model input; read with the evidence status and period context.

Operating margin16.3%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years32.3%Model input; read with the evidence status and period context.

FCF margin20.0%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.